Your browser doesn't support javascript.
loading
Comments on pre-fibrotic myelofibrosis and how should it be managed.
Barbui, Tiziano; Thiele, Juergen; Gisslinger, Heinz; Orazi, Attilio; Vannucchi, Alessandro M; Gianelli, Umberto; Beham-Schmid, Christine; Tefferi, Ayalew.
Afiliación
  • Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Thiele J; Institute of Pathology, University of Cologne, Cologne, Germany.
  • Gisslinger H; Department of Internal Medicine I, Division of Haematology and Haemostaseology, Medical University of Vienna, Vienna, Austria.
  • Orazi A; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Vannucchi AM; Department of Experimental and Clinical Medicine, Centre of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Gianelli U; Division of Pathology, Department of Pathophysiology and Transplantation, University of Milan, and IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, Milan, Italy.
  • Beham-Schmid C; Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Tefferi A; Mayo Clinic, Rochester, MN, USA.
Br J Haematol ; 186(2): 358-360, 2019 07.
Article en En | MEDLINE | ID: mdl-30847907

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria / Trombocitemia Esencial Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria / Trombocitemia Esencial Límite: Humans Idioma: En Revista: Br J Haematol Año: 2019 Tipo del documento: Article País de afiliación: Italia
...